Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Abandoned drugs
PF-219,061
Другие языки:

PF-219,061

Подписчиков: 0, рейтинг: 0
PF-219,061
PF-219,061 Structural Formulae.png
Clinical data
Routes of
administration		 Nasal
Legal status
Legal status
  • Investigational (discontinued)
Identifiers
  • (R)-3-(4-propylmorpholin-2-yl)phenol
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula C13H19NO2
Molar mass 221.300 g·mol−1
3D model (JSmol)
  • CCCN1CCO[C@@H](C1)C2=CC(=CC=C2)O
  • InChI=1S/C13H19NO2/c1-2-6-14-7-8-16-13(10-14)11-4-3-5-12(15)9-11/h3-5,9,13,15H,2,6-8,10H2,1H3/t13-/m0/s1 ☒N
  • Key:WYEGTIGJSHGEID-ZDUSSCGKSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

PF-219,061 is a drug that was under development by Pfizer which acts as a potent and highly selective agonist for the dopamine D3 receptor. It was under development as a potential medication for the treatment of female sexual dysfunction. It did not advance into clinical trials.

See also


Новое сообщение